Pharmaceutical companies begin paying the Food and Drug Administration.
Date: 1992
The pharmaceutical industry begins paying the U.S. Food and Drug Administration (FDA) millions of dollars in user fees in order to speed up the drug approval process.
Today, these fees fund more than half of the agency's critical drug review process.